A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route

Clinical trial NCT02712554 · COMPLETED

Trial details

NCT number: NCT02712554
Sponsor: Charleston Laboratories, Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pain Nausea Vomiting

Start date: 2015-06-01
Primary completion: 2015-09-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.